MODARRO Trademark

Trademark Overview

On Thursday, July 22, 2010, a trademark application was filed for MODARRO with the United States Patent and Trademark Office. The USPTO has given the MODARRO trademark a serial number of 85090626. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 9, 2015. This trademark is owned by Glaxo Group Limited. The MODARRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
modarro

General Information

Serial Number85090626
Word MarkMODARRO
Filing DateThursday, July 22, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 9, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 27, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, March 9, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 9, 2015ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 26, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 25, 2014EXTENSION 3 GRANTED
Thursday, June 19, 2014EXTENSION 3 FILED
Thursday, June 19, 2014TEAS EXTENSION RECEIVED
Friday, January 31, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 30, 2014EXTENSION 2 GRANTED
Monday, December 9, 2013EXTENSION 2 FILED
Friday, January 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 9, 2013TEAS EXTENSION RECEIVED
Thursday, August 1, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2013EXTENSION 1 GRANTED
Tuesday, July 30, 2013EXTENSION 1 FILED
Tuesday, July 30, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 5, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 11, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 11, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 21, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 2, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 31, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 30, 2012REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, April 30, 2012ASSIGNED TO LIE
Thursday, October 27, 2011REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, April 27, 2011REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, October 27, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 27, 2010LETTER OF SUSPENSION E-MAILED
Wednesday, October 27, 2010SUSPENSION LETTER WRITTEN
Wednesday, October 27, 2010EXAMINER'S AMENDMENT ENTERED
Wednesday, October 27, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 27, 2010EXAMINERS AMENDMENT E-MAILED
Wednesday, October 27, 2010EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 26, 2010ASSIGNED TO EXAMINER
Tuesday, July 27, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 26, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

modarro pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic